Loading Sign Up for
Dosing
Reminders
Loading

Indication

NGENLA is a prescription product for the treatment of growth failure in children 3 years of age and older who do not make enough growth hormone on their own. This condition is called growth hormone deficiency (GHD).

Download these tools and educational resources
Frequently Asked Questions (FAQs) Flash Card

Get answers to some of the most commonly asked questions about pGHD and NGENLA.

DownloadLoading
Doctor Discussion Guide

This guide can help you prepare for your child's upcoming appointment. Partner with your doctor to see if NGENLA is right for your child.

DownloadLoading
Patient Brochure

Learn more about pediatric growth hormone deficiency (pGHD), NGENLA, and support services.

DownloadLoading
Frequently Asked Questions (FAQs) Flash Card

Get answers to some of the most commonly asked questions about pGHD and NGENLA.

DownloadLoading
How to Use NGENLA Placemat

Follow these step-by-step instructions when giving your child his or her once-weekly NGENLA injection.

DownloadLoading
How to Use NGENLA Video

Follow these instructions to learn how to use once-weekly NGENLA.

DownloadLoading
Other Resources
Growth Chart

Use the growth chart to see how your child is growing compared to children of the same age.

See moreLoading
MyNgenla Plan

Use MyNgenla Plan to see how many pens are needed to meet your dosing needs.

See moreLoading
NGENLA Navigator

The NGENLA Navigator program supports you and your child throughout their treatment journey. Sign up for our NGENLA Navigator program and receive information to help you better understand your child's treatment with NGENLA.

See moreLoading

  For dosing reminders, text MYNGENLA to 46286

View mobile Terms and Conditions at engagedrx.com/pghd. Msg & Data rates may apply. Msg frequency varies. Text HELP for info, STOP to opt out. Pfizer’s Privacy Policy can be found at pfizer.com/privacy.

Important Safety Information & Use

INDICATION
NGENLA is a prescription product for the treatment of growth failure in children 3 years of age and older who do not make enough growth hormone on their own. This condition is called growth hormone deficiency (GHD).   
IMPORTANT SAFETY INFORMATION
  • Growth hormone should not be used in children after the growth plates have closed.
  • Growth hormone should not be used in children with some types of eye problems
    caused by diabetes (diabetic retinopathy).
  • Growth hormone should not be used in children who have cancer or other tumors.
  • Growth hormone should not be used in children who are critically ill because of some
    types of heart or stomach surgery, trauma, or breathing (respiratory) problems.
  • Growth hormone should not be used in children with Prader-Willi syndrome who are
    very overweight or have breathing problems including sleep apnea.
  • NGENLA should not be used by children who have had an allergic reaction to
    somatrogon-ghla or any of the ingredients in NGENLA. Look for prompt medical
    attention in case of an allergic reaction.
  • Some children have developed diabetes mellitus while taking growth hormone. Dosages
    of diabetes medicines may need to be adjusted during treatment with NGENLA.
    Children should be watched carefully if NGENLA is given along with glucocorticoid
    therapy and/or other drugs that are processed by the body in the same way.
  • In childhood cancer survivors, treatment with growth hormone may raise the likelihood
    of a new tumor, particularly some benign (non-cancerous) brain tumors. This likelihood
    may be higher in children who were treated with radiation to the brain or head. Your
    child’s health care provider will need to check your child for a return of cancer or a
    tumor.
  • Children treated with growth hormone have had increased pressure in the brain. If your
    child has headaches, eye problems, nausea (feeling like you are going to be sick), or
    vomiting, contact your child’s health care provider.
  • NGENLA may decrease thyroid hormone levels. Decreased thyroid hormone levels may
    change how well NGENLA works. Your child’s health care provider will do blood tests to
    check your child’s hormone levels.
  • Children treated with growth hormone should be checked regularly for low serum
    cortisol levels and/or the need to increase the dose of the glucocorticoids they are
    taking.
  • In children experiencing fast growth, curvature of the spine may develop or worsen. This
    is also called scoliosis. Children with scoliosis should be checked regularly to make sure
    their scoliosis does not get worse during their growth hormone therapy.
  • Use a different area on the body for each injection. This can help to avoid skin problems
    such as lumpiness or soreness.
  • Growth hormone treatment may cause serious and constant stomach (abdominal) pain.
    This could be a sign of pancreatitis. Tell your child’s health care provider if your child has
    any new stomach (abdominal) pain.
  • In studies of NGENLA in children with GHD, side effects included injection site reactions
    such as pain, swelling, rash, itching, or bleeding. Other side effects were the common
    cold, headache, fever (high temperature), low red blood cells (anemia), cough, vomiting,
    decreased thyroid hormone levels, stomach pain, rash, or throat pain.
  • A health care provider will help you with the first injection. He or she will also train you
    on how to inject NGENLA.
  • Rx only

This site is intended only for U.S. residents. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only and is not intended to replace discussions with a healthcare provider.

© 2024 Pfizer Inc. All rights reserved.
PP-SMT-USA-0408